P. P. Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 02-01-2025
- Paid Up Capital ₹ 1.24 Cr
as on 02-01-2025
- Company Age 16 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.04 Cr
as on 02-01-2025
- Revenue -7.43%
(FY 2021)
- Profit 279.95%
(FY 2021)
- Ebitda 37.64%
(FY 2021)
- Net Worth 980.03%
(FY 2021)
- Total Assets 25.40%
(FY 2021)
About P. P. Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.24 Cr.
The company currently has active open charges totaling ₹1.04 Cr.
Deepak Patkar and Abhijit Pawar serve as directors at the Company.
- CIN/LLPIN
U85100PN2008PTC132038
- Company No.
132038
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 May 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at P. P. Diagnostics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhijit Pawar  | Director | 16-May-2008 | Current |
| Deepak Patkar | Director | 16-May-2008 | Current |
Financial Performance of P. P. Diagnostics.
P. P. Diagnostics Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 7.43% decrease. The company also saw a substantial improvement in profitability, with a 279.95% increase in profit. The company's net worth Soared by an impressive increase of 980.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of P. P. Diagnostics?
In 2021, P. P. Diagnostics had a promoter holding of 100.00%. The company had 4 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Radiology Events Education Fest Associat Es LlpActive 6 years 7 months
Deepak Patkar is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 07 Jul 2017 | ₹2.97 M | Open |
Others Creation Date: 10 May 2016 | ₹5.40 M | Open |
Abn Amro Bank N.V. Creation Date: 29 May 2009 | ₹1.99 M | Open |
How Many Employees Work at P. P. Diagnostics?
P. P. Diagnostics has a workforce of 20 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of P. P. Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped P. P. Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
